Dianthus Therapeutics, INC /DE/ S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Dianthus Therapeutics files an amendment to its S-1 registration statement to register the resale of common stock by selling stockholders.
NASDAQ
Dianthus Therapeutics amends its S-1 registration statement to register the resale of up to 21,326,988 shares of common stock by selling stockholders.